MO St. Louis의 크론병 임상 시험
크론병 관련 연구 19개가 St. Louis 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
피험자 모집 중2상
- Specialists In Gastroenterology /ID# 283939, St Louis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
피험자 모집 중1상
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- 외 1개
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
피험자 모집 중3상
- Washington University School of Medicine ( Site 5058), St Louis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
피험자 모집 중4상
- SSM Health Medical Group, Bridgeton · 15마일 거리
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
피험자 모집 중2상
- Washington University /ID# 266938, St Louis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
피험자 모집 중3상
- Washington University School of Medicine, St Louis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중3상
- Washington University School of Medicine-Site Number: 8400075, St Louis
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중3상
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
피험자 모집 중3상
- Washington University School of Medicine, St Louis
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
피험자 모집 중2상
- KAD Clinical Research, St Louis
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
피험자 모집 중2상
- SSM Health DePaul Hospital- St. Louis, Bridgeton · 15마일 거리
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
피험자 모집 중2상
- KAD Clinical Research, St Louis
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
피험자 모집 중4상
- Washington University School of Medicine, St Louis
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
피험자 모집 중2상
- Washington University, St. Louis, St Louis
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
피험자 모집 중2상
- Washington University School of Medicine, St Louis
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
피험자 모집 중2상
- Investigational Site Number: 8400013, St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
피험자 모집 중2상
- Mirador Therapeutics Selected Site, Bridgeton · 15마일 거리
Treatment of Moderate to Severe Refractory Crohn's Disease
피험자 모집 중1/2상
- Washington University in St. Louis, St Louis
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
피험자 모집 중관찰 연구
- Washington University in St Louis School of Medicine, St Louis
다른 도시의 크론병 시험
- New York City, NY연구 35개
- Boston, MA연구 19개
- Miami, FL연구 19개
- Cleveland, OH연구 19개
- Tyler, TX연구 17개
- Houston, TX연구 17개
- Orlando, FL연구 17개
- Atlanta, GA연구 17개
- San Antonio, TX연구 15개
- San Diego, CA연구 15개
- Los Angeles, CA연구 15개
- Colorado Springs, CO연구 13개
St. Louis의 다른 연구
- 비소세포폐암연구 73개
- 유방암연구 64개
- 전이성 암연구 54개
- 대장직장암연구 50개
- 암 (전체)연구 46개
- 전립선암연구 46개
- 폐암연구 39개
- 난소암연구 38개
- 췌장암연구 33개
- 자궁내막암연구 29개
- 두경부 편평세포암연구 28개
- 심부전연구 26개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.